Kamil Musilek Selected Research

cyclohexyl methylphosphonofluoridate (cyclosarin)

6/2009	A comparison of reactivating and therapeutic efficacy of newly-developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
3/2009	Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
1/2009	An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kamil Musilek Research Topics

Disease

42	Poisoning 09/2022 - 03/2006
20	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 10/2010
11	Organophosphate Poisoning 01/2021 - 10/2008
8	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 06/2014
8	Neoplasms (Cancer) 01/2022 - 11/2015
4	Myasthenia Gravis 02/2016 - 03/2010
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2017
2	Amyloid Plaque 01/2022 - 01/2019
2	Epilepsy (Aura) 12/2020 - 01/2015
1	Schizophrenia (Dementia Praecox) 03/2022
1	Psychotic Disorders (Schizoaffective Disorder) 03/2022
1	Mental Disorders (Mental Disorder) 03/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2021
1	Inflammation (Inflammations) 05/2021
1	Mycoses (Diseases, Fungus) 05/2021
1	Amnesia (Dissociative Amnesia) 01/2021
1	Hypoxia (Hypoxemia) 11/2020
1	Parkinson Disease (Parkinson's Disease) 03/2020
1	Intellectual Disability (Idiocy) 03/2020
1	Malaria 01/2020
1	Vomiting 01/2020
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2020
1	Nausea 01/2020
1	Pain (Aches) 06/2016
1	Huntington Disease (Huntington's Disease) 01/2015
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2015
1	Nervous System Diseases (Neurological Disorders) 01/2015

Drug/Important Bio-Agent (IBA)

38	OximesIBA 09/2022 - 03/2006
22	tabunIBA 09/2022 - 11/2007
16	AcetylcholinesteraseIBA 01/2021 - 01/2008
11	Obidoxime Chloride (Obidoxime)IBA 09/2018 - 01/2008
8	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2018 - 03/2010
7	Nerve AgentsIBA 01/2019 - 12/2009
7	Atropine FDA LinkGeneric 09/2018 - 03/2006
7	Trimedoxime (Trimedoxime Bromide)IBA 04/2015 - 01/2008
6	EnzymesIBA 01/2021 - 11/2015
6	asoxime chloride (H16)IBA 03/2015 - 12/2008
5	Amyloid (Amyloid Fibrils)IBA 01/2022 - 12/2010
5	AntidotesIBA 01/2021 - 03/2009
5	Cholinesterases (Cholinesterase)IBA 01/2021 - 03/2009
4	benzothiazoleIBA 01/2021 - 01/2015
4	Organophosphorus CompoundsIBA 01/2021 - 06/2015
4	Amyloid beta-PeptidesIBA 03/2020 - 01/2016
4	Oxidoreductases (Dehydrogenase)IBA 03/2020 - 12/2010
3	LigandsIBA 03/2022 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
3	GoldIBA 01/2021 - 10/2016
3	Monoamine Oxidase (MAO)IBA 01/2021 - 01/2017
3	Biological ProductsIBA 12/2019 - 02/2013
3	Cholinergic Agents (Cholinergics)IBA 01/2019 - 02/2016
3	Diazepam (Valium)FDA LinkGeneric 09/2018 - 01/2011
3	OrganophosphatesIBA 01/2018 - 03/2012
3	Paraoxon (E600)IBA 06/2015 - 11/2007
3	cyclohexyl methylphosphonofluoridate (cyclosarin)IBA 06/2009 - 01/2009
2	AntioxidantsIBA 05/2021 - 12/2020
2	Tacrine (Cognex)FDA Link 01/2021 - 11/2011
2	Anticonvulsants (Antiepileptic Drugs)IBA 12/2020 - 01/2011
2	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 07/2019 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2015
2	pralidoxime (Protopam Chloride)FDA Link 07/2011 - 09/2008
2	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 04/2011 - 03/2010
2	CarbamatesIBA 01/2011 - 03/2010
2	1- (4- carbamoylpyridinium)- 4- (3- fluoro- 4- hydroxyiminomethylpyridinium)- but- 2- eneIBA 11/2010 - 08/2010
2	Cholinergic Antagonists (Anticholinergics)IBA 10/2008 - 03/2006
1	Antipsychotic Agents (Antipsychotics)IBA 03/2022
1	cariprazineIBA 03/2022
1	Amphetamine (Amfetamine)FDA LinkGeneric 03/2022
1	Serotonin (5 Hydroxytryptamine)IBA 03/2022
1	Dopamine (Intropin)FDA LinkGeneric 03/2022
1	Serotonin ReceptorsIBA 03/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2022
1	N-dodecyl-L-lysine amideIBA 03/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	JNK Mitogen-Activated Protein KinasesIBA 01/2022
1	BP-1-102IBA 12/2021
1	Cytotoxins (Cytolysins)IBA 12/2021
1	PhytochemicalsIBA 05/2021
1	Glycogen Synthase KinasesIBA 01/2021
1	Scopolamine (Hyoscine)FDA Link 01/2021
1	Calcium Channels (Calcium Channel)IBA 01/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 12/2020
1	Hormones (Hormone)IBA 11/2020
1	T-2 Toxin (T 2 Toxin)IBA 11/2020
1	QuinolonesIBA 05/2020
1	InsecticidesIBA 01/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	SaltsIBA 12/2019
1	Ammonium CompoundsIBA 12/2019
1	AcidsIBA 12/2018
1	Casein Kinase I (Casein Kinase 1)IBA 12/2018
1	GuanidinesIBA 01/2017
1	frentizoleIBA 01/2017
1	ThioureaIBA 01/2017
1	DichlorvosIBA 01/2016
1	FlavonesIBA 11/2015
1	SarinIBA 03/2015
1	Peptides (Polypeptides)IBA 01/2015

Therapy/Procedure

7	Therapeutics 01/2021 - 06/2015
1	Drug Therapy (Chemotherapy) 01/2020
1	Rejuvenation 10/2016